Clinical trial looking for participants for new Alzheimer's drug

PHOENIX — The recent approval of a new Alzheimer's drug is opening the door for researchers to expand their work and validate the work they've already done. Now they're recruiting local study participants.

Researchers working on the AHEAD study believe there are indicators of Alzheimer's that can show up even 20 years before the disease takes hold. They've identified a protein, detectable in blood tests, that signals your risk of Alzheimer's. Now, they need to work backward to confirm an early intervention treatment so doctors can order those blood tests.

"The approval and demonstration by the FDA validates that we really need to start sooner before there's any symptoms," said Dr. Goldfarb.

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Major Blow as Experimental HIV Vaccine Fails in Late Clinical TrialThe decades-long quest to develop a HIV vaccine has been dealt another major blow, with the 'last true candidate in development' failing to prevent infections any better than a placebo in late-stage clinical trials.
Source: ScienceAlert - 🏆 63. / 68 Read more »